Clinical Trial Update: Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on fecal microbiota transplant with Promicrobioma for treatment and recurrence of Clostridium difficile infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Drugs mentioned

• Promicrobioma

Snippet

Sponsor: Hospital Universitario Evangelico de Curitiba | Conditions: Clostridium Difficile Infections | Phase 3 | Status: UNKNOWN